Terms: = Testicular cancer AND PR, PGR, progesterone receptor AND Prognosis
21 results:
1. Consolidative radiation in partial responders/unresectable/recurrent disease after first-line/salvage chemotherapy in poor-risk nonseminomatous germ cell tumor prolongs survival: A new paradigm?
Tiwari S; Agrawal S
J Cancer Res Ther; 2023; 19(2):457-460. PubMed ID: 37313917
[TBL] [Abstract] [Full Text] [Related]
2. testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Göbel U; Calaminus G; Haas R; Teske C; Schönberger S; Schneider DT; Leuschner I; Harms D
Klin Padiatr; 2014 Nov; 226(6-7):316-22. PubMed ID: 25431864
[TBL] [Abstract] [Full Text] [Related]
3. Estrogen receptor content in malignant breast tumors in men--a review.
Olsson H
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):283-7. PubMed ID: 14973390
[TBL] [Abstract] [Full Text] [Related]
4. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
[TBL] [Abstract] [Full Text] [Related]
5. [Paratesticular rhabdomyosarcoma].
Mamveev BP; Gurariĭ LL; Volkova MI; Matveev VB; Khalaf'ian EA
Urologiia; 2003; (2):18-21. PubMed ID: 12811918
[TBL] [Abstract] [Full Text] [Related]
6. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract] [Full Text] [Related]
7. Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Ayash LJ; Clarke M; Silver SM; Braun T; Uberti J; Ratanatharathorn V; Reynolds C; Ferrara J; Broun ER; Adams PT
Bone Marrow Transplant; 2001 May; 27(9):939-47. PubMed ID: 11436104
[TBL] [Abstract] [Full Text] [Related]
8. [Results of treatment for germ cell tumor--dose intensity of chemotherapy and residual masses after chemotherapy].
Matsuzaki J; Miyoshi Y; Miura T
Hinyokika Kiyo; 2000 Dec; 46(12):879-86. PubMed ID: 11211804
[TBL] [Abstract] [Full Text] [Related]
9. Paclitaxel and cisplatin as salvage treatment in patients with non-seminomatous germ cell tumour who failed to achieve a complete remission on induction chemotherapy.
Tjulandin SA; Titov DA; Breder VV; Sidorova NJ; Popov AJ; Kupchan DZ; Garin AM
Clin Oncol (R Coll Radiol); 1998; 10(5):297-300. PubMed ID: 9848329
[TBL] [Abstract] [Full Text] [Related]
10. Gynandroblastoma with elements resembling juvenile granulosa cell tumor.
Broshears JR; Roth LM
Int J Gynecol Pathol; 1997 Oct; 16(4):387-91. PubMed ID: 9421080
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria].
Mikami K; Nakagawa S; Sugimoto K; Nomoto T; Urano S; Watanabe H; Iwamoto N; Yamazaki S; Hiratake Y; Maegawa M
Hinyokika Kiyo; 1997 Aug; 43(8):561-6. PubMed ID: 9310778
[TBL] [Abstract] [Full Text] [Related]
12. Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort.
Wessalowski R; Blohm M; Calaminus G; Engert J; Harms D; Krause I; Kruck H; Grüttner HP; Pape H; Göbel U
Klin Padiatr; 1997; 209(4):250-6. PubMed ID: 9293458
[TBL] [Abstract] [Full Text] [Related]
13. Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Bokemeyer C; Beyer J; Metzner B; Ruther U; Harstrick A; Weissbach L; Kohrmann U; Verbeek W; Schmoll HJ
Ann Oncol; 1996 Jan; 7(1):31-4. PubMed ID: 9081388
[TBL] [Abstract] [Full Text] [Related]
14. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
[TBL] [Abstract] [Full Text] [Related]
15. Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy.
Kattan J; Culine S; Terrier-Lacombe MJ; Théodore C; Droz JP
Ann Oncol; 1993 Dec; 4(10):871-5. PubMed ID: 8117607
[TBL] [Abstract] [Full Text] [Related]
16. [Treatment results and practical dosage of PVB therapy for advanced testicular tumors].
Seguchi T; Iwasaki A; Sugao H; Nakano E; Sonoda T
Nihon Hinyokika Gakkai Zasshi; 1990 Sep; 81(9):1357-61. PubMed ID: 1700180
[TBL] [Abstract] [Full Text] [Related]
17. [Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)].
Baume D; Pico JL; Droz JP; Ostronoff M; Azab M; Gilles E; Ghosn M; Salloum E; Gouyette A; Beaujean F
Bull Cancer; 1990; 77(2):169-80. PubMed ID: 2156588
[TBL] [Abstract] [Full Text] [Related]
18. Management of advanced metastatic germ cell tumours.
Daugaard G; Hansen HH; Rørth M
Int J Androl; 1987 Feb; 10(1):319-24. PubMed ID: 2438225
[TBL] [Abstract] [Full Text] [Related]
19. High-dose cisplatin and VP-16 with bleomycin, in the management of advanced metastatic germ cell tumors.
Daugaard G; Rŗth M
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):477-85. PubMed ID: 2426115
[TBL] [Abstract] [Full Text] [Related]
20. Chemotherapy with adriamycin and vincristine alternated with cyclophosphamide and actinomycin D in testicular germ cell tumors refractory to cisplatin, vinblastine and bleomycin.
Crispino S; Pizzocaro G; Marchini S; Monfardini S
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):251-6. PubMed ID: 2423339
[TBL] [Abstract] [Full Text] [Related]
[Next]
